| human | Q5 |
| P7893 | CIÊNCIAVITAE ID | 3C1C-A6C2-71ED |
| P496 | ORCID iD | 0000-0002-7417-0091 |
| P3829 | Publons author ID | 2622196 |
| P1053 | ResearcherID | I-2975-2013 |
| P1153 | Scopus author ID | 7202085681 |
| P108 | employer | Faculty of Pharmacy, University of Lisbon | Q10279482 |
| University of Minnesota system | Q14552696 | ||
| P734 | family name | Castro | Q1049855 |
| Castro | Q1049855 | ||
| Castro | Q1049855 | ||
| P735 | given name | Rui | Q20000233 |
| Rui | Q20000233 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q96118167 | A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma |
| Q46483255 | A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid. |
| Q36293295 | Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation |
| Q37330901 | Activation of necroptosis in human and experimental cholestasis. |
| Q34619432 | Administration of tauroursodeoxycholic acid (TUDCA) reduces apoptosis following myocardial infarction in rat. |
| Q57760188 | Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis |
| Q54599587 | Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease. |
| Q43087408 | Apoptosis in transgenic mice expressing the P301L mutated form of human tau. |
| Q42546212 | Corrigendum: Inhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocellular apoptosis |
| Q50926535 | Cytotoxic bile acids, but not cytoprotective species, inhibit the ordering effect of cholesterol in model membranes at physiologically active concentrations. |
| Q36197853 | Deoxycholic acid modulates cell death signaling through changes in mitochondrial membrane properties |
| Q112729148 | Diet-dependent gut microbiota impacts on adult neurogenesis through mitochondrial stress modulation |
| Q57760185 | Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes |
| Q99555837 | Evaluation of Tissue and Circulating miR-21 as Potential Biomarker of Response to Chemoradiotherapy in Rectal Cancer |
| Q48521410 | Functional modulation of nuclear steroid receptors by tauroursodeoxycholic acid reduces amyloid beta-peptide-induced apoptosis. |
| Q57760193 | Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients |
| Q104260361 | Host miRNA-21 promotes liver dysfunction by targeting small intestinal Lactobacillus in mice |
| Q34212063 | Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid |
| Q36333430 | Inhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocelular apoptosis. |
| Q44980175 | Inhibition of the E2F-1/p53/Bax pathway by tauroursodeoxycholic acid in amyloid beta-peptide-induced apoptosis of PC12 cells |
| Q95656627 | Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning? |
| Q34168368 | Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance. |
| Q41610131 | MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism |
| Q35008686 | MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. |
| Q44955749 | Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes. |
| Q51656629 | Nanoformulations of a potent copper-based aquaporin inhibitor with cytotoxic effect against cancer cells. |
| Q45982367 | Naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylates: potent, non-cytotoxic, antiapoptotic agents. |
| Q34044526 | Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis. |
| Q28568025 | Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-beta1-induced apoptosis in rat hepatocytes |
| Q57746323 | Progesterone and Caspase-3 Activation in Equine Cyclic Corpora Lutea |
| Q38202220 | Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease. |
| Q92363095 | Skeletal muscle miR-34a/SIRT1:AMPK axis is activated in experimental and human non-alcoholic steatohepatitis |
| Q30620946 | Synthesis and evaluation of water-soluble prodrugs of ursodeoxycholic acid (UDCA), an anti-apoptotic bile acid. |
| Q39107877 | Synthesis, G-quadruplex stabilisation, docking studies, and effect on cancer cells of indolo[3,2-b]quinolines with one, two, or three basic side chains. |
| Q60895713 | Targeting miR-506 in primary biliary cirrhosis to support the HCO3− umbrella |
| Q40241292 | Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells. |
| Q37384925 | Tauroursodeoxycholic acid prevents E22Q Alzheimer's Abeta toxicity in human cerebral endothelial cells. |
| Q35022852 | Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats |
| Q55448142 | The Emerging Role of microRNAs in Aquaporin Regulation. |
| Q44931390 | The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of bad via phosphatidylinositol 3-kinase in glutamate-induced apoptosis of rat cortical neurons. |
| Q88954155 | Towards a definite mouse model of NAFLD |
| Q42921163 | Ursodeoxycholic acid modulates the ubiquitin-proteasome degradation pathway of p53. |
| Q38602520 | Ursodeoxycholic acid: effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients. |
| Q26741931 | With mouse age comes wisdom: A review and suggestions of relevant mouse models for age-related conditions |
| Q37643931 | c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver. |
| Q36962611 | miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells. |
| Q46219713 | miR-143 over-expression reduces the growth of xenograft tumors from colon carcinoma cells |
| Q34013744 | miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation |
| Q33815927 | miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice |
| Q60895711 | miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease |
| Q47304510 | miRNA-21 ablation protects against liver injury and necroptosis in cholestasis. |
| Q37613275 | p53 and the regulation of hepatocyte apoptosis: implications for disease pathogenesis. |
| Q28568391 | p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis |
Search more.